APIs for research and impurities
Subcategories of "APIs for research and impurities"
- Aminoacids and derivatives(12,440 products)
- Anthraquinones and derivatives(407 products)
- Benzimidazole and Imidazole Derivatives(10,465 products)
- Benzodiazepine Derivatives(335 products)
- Carbohydrates and glycoconjugates(5,388 products)
- Esters and Derivatives(42,306 products)
- Fatty Acids and Lypidic Derivatives(32,487 products)
- Flavonoids and Polyphenols(17,101 products)
- Free Radicals and Oxidant/Reducing Agents(214 products)
- Ketones and derivatives(2,692 products)
- Natural and semi-synthetic antibiotics(6,410 products)
- Nitriles and Cyano Derivatives(3,070 products)
- Nitrosamines and Derivatives(55 products)
- Nucleosides and Nucleotides(3,492 products)
- Organic Phosphates and Phosphonates(1,205 products)
- Organic Sulphonates and Sulphates(10,451 products)
- Organometallics(4,425 products)
- Others(6,340 products)
- Peptides and Proteins(3,163 products)
- Polymers and Derivatives(100 products)
- Purines and Pyrimidine Derivatives(8,975 products)
- Quinazoline and Quinoline Derivatives(66,222 products)
- Quinones and Derivatives(24,379 products)
- Salts and Derivatives of Active Pharmaceutical Ingredients (API)(92,956 products)
- Steroids and Derivatives(4,987 products)
- Sulfonamides and Derivatives(2,607 products)
- Terpenoids and Derivatives(3,860 products)
- Thiazolidinediones and Thiopyrans(2,755 products)
- β-Adrenergic Compounds(231 products)
Found 66881 products of "APIs for research and impurities"
N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-D-valine
CAS:N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-D-valine is a potent and selective inhibitor of the enzyme lipase. It prevents the hydrolysis of triglycerides by competitively binding to the active site of lipase. This inhibition leads to an increase in serum levels of triglycerides, which are associated with cardiometabolic risk factors. Novartis developed this drug as an alternative to sacubitril/valsartan, which is used for the treatment of heart failure. The pharmacokinetics and pharmacodynamics of this drug are similar to those of sacubitril/valsartan. N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-D-Formula:C24H29N5O3Purity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:435.52 g/molTenofovir isoproxil monoester
CAS:Tenofovir isoproxil monoester is a prodrug of Tenofovir, which is an antiviral drug. Tenofovir prevents the growth of HIV by interfering with the synthesis of viral DNA. The process development stage involves converting Tenofovir to its disoproxil monoester form, which has been shown to have greater antiviral activity than Tenofovir alone. This conversion process involves condensing one molecule of fumarate with two molecules of tenofovir, forming tenofovir disoproxil fumarate (TFD). TFD can be converted back to Tenofovir using hydrolysis and hydrogenation. Impurities in TFD include isopropyl tenofovir and unidentified impurities that are not present in the parent drug, tenofovir. Tenofovir Disoproxil Fumarate was also shown to be more potent than TFD and is undergoing clinical trials forFormula:C14H22N5O7PPurity:Min. 97 Area-%Color and Shape:White/Off-White SolidMolecular weight:403.33 g/mol6-Methylene progesterone acetate
CAS:Controlled Product6-Methylene progesterone acetate is a polymerase chain inhibitor that inhibits the synthesis of viral and cellular DNA. It was first isolated from infected cells in tissue culture and has been shown to inhibit the growth of a wide range of viruses, including rabies, herpes simplex, herpes zoster, cytomegalovirus, varicella-zoster virus, and vesicular stomatitis virus. 6MPAA also blocks the production of gene products in mammalian cells by preventing RNA synthesis. This drug can be used as an antiviral agent for treatment of enteritis caused by rotavirus infection. 6MPAA binds to gp2 protein on the surface of virus particles and prevents this protein from interacting with polyclonal antibodies or monoclonal antibodies to prevent antibody response.
Formula:C24H32O4Purity:Min. 95%Color and Shape:PowderMolecular weight:384.51 g/molChlorhexidine digluconate impurity K dihydrochloride
CAS:Chlorhexidine digluconate impurity K dihydrochloride is a drug product that is an analytical standard. It is a natural metabolite of chlorhexidine digluconate, which is a synthetic compound. Chlorhexidine digluconate impurity K dihydrochloride has been shown to have anti-inflammatory properties and to inhibit the production of prostaglandins in animal studies. The pharmacopoeia designation for this drug product is USP/NF.Formula:C22H29Cl2N9OPurity:Min. 95%Color and Shape:PowderMolecular weight:506.43 g/molDesmethyl fondenafil
CAS:Fondenafil is a drug that belongs to the class of PDE-5 inhibitors. It is used for the treatment of erectile dysfunction and pulmonary hypertension. Fondenafil is chemically related to sildenafil, but lacks the ethyl group. Fondenafil has been shown to be effective in treating insulin resistance by increasing glucose uptake in adipose tissue and skeletal muscle cells. Fondenafil also reduces blood pressure, cholesterol, and triglyceride levels in patients with metabolic syndrome.Formula:C23H30N6O3Purity:Min. 95%Molecular weight:438.5 g/mol3-O-Methylcarbidopa
CAS:Controlled Product3-O-Methylcarbidopa is a drug that belongs to the class of dopa decarboxylase inhibitors. It is an inactive prodrug, which is converted into its active form by hydrolysis in the body. 3-O-Methylcarbidopa has been shown to have a plasma concentration that can be detected, with an elimination rate of about 4 hours. The active substance is found in the particle size range of 0.1 to 1 micrometer and can be analyzed using chromatographic methods. 3-O-Methylcarbidopa is primarily used for the treatment of Parkinson's disease, but also has potential applications in other diseases such as Alzheimer's disease, depression and schizophrenia.Purity:Min. 95%Molecular weight:240.26Pantoprazole sodium hydrate - Mixture of impurities D and F
CAS:Pantoprazole sodium hydrate is a custom synthesis that is used as a drug product. The CAS number for this compound is 624742-53-6. This compound has the following impurities: D and F. Pantoprazole sodium hydrate has been shown to be metabolized in vitro by human liver microsomes to its metabolites, including the following: (1) pantoprazol acid, (2) 4-hydroxypantoprazol acid, (3) 4-hydroxyisoxazole acid, and (4) 5-(4-hydroxyphenyl)-2H-1,2-benzoxazin-3(4H)-one. The metabolite 4-hydroxypantoprazol acid has been found to be pharmacologically active in animal models of gastric ulceration and healing.Formula:C17H17F2N3O4SPurity:Min. 95%Color and Shape:Off-white to yellow powder.Molecular weight:397.4 g/molN-[1-(S)-(-)-(1-Naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-aminopropane hydrochloride
CAS:N-[1-(S)-(-)-(1-Naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]-1-aminopropane hydrochloride is an analytical reagent that is used in biological and pharmaceutical research. It is a potent inhibitor of parathyroid hormone release and has been shown to be a potential biomarker for hyperparathyroidism. The drug is also used as a control analysis in polymerase chain reaction experiments. When administered to animals, it has been shown to reduce the thermal expansion of cartilage tissue and increase the rate of bone resorption. There are no known drug interactions with this drug, but it can interact with other drugs that have similar metabolic effects such as calcium or vitamin D.Formula:C22H22F3N·HClPurity:Min. 95%Color and Shape:White PowderMolecular weight:393.87 g/molPantoprazole N-oxide sodium
CAS:Pantoprazole N-oxide sodium is a custom synthesis drug product that is being developed as an impurity standard in the synthesis of Pantoprazole. The compound is also used as a pharmacopoeia analytical standard and a HPLC standard.Formula:C16H15F2N3O5S·NaPurity:Min. 95%Color and Shape:PowderMolecular weight:422.36 g/molSimvastatin hydroxy acid ethyl ester
CAS:Simvastatin hydroxy acid ethyl ester is a solvated form of simvastatin, an investigational drug for the treatment of dyslipidemia. The ammonium salt was prepared by alcoholysis with ethanol. The elution process was carried out using an acetonitrile-water mixture and chromatography on silica gel. Preparation methods were investigated to determine the best preparative procedure that would yield pure material. This compound has been investigated as a possible therapeutic agent for the treatment of midbody diseases such as familial amyloidotic polyneuropathy and Alzheimer's disease.Formula:C27H44O6Purity:Min. 95%Color and Shape:Colourless To Pale Yellow LiquidMolecular weight:464.63 g/molHydrocortisone dimer impurity 4
Hydrocortisone dimer impurity 4 is an impurity found in the drug product Hydrocortisone. It is a natural, API impurity, CAS No. 5949-44-8, and has been synthesized for use as an analytical standard. The substance's Metabolism studies were conducted using rats and mice, and it was found to be metabolized mainly by hydrolysis with glucuronidases or esterases. It also has a high purity of >99%.Purity:Min. 95%Acyclovir acetate
CAS:Acyclovir is an antiviral agent that prevents the growth of herpes simplex virus. Acyclovir is a prodrug, which is converted to acycloguanosine 5'-triphosphate (ACV-TP) in vivo. ACV-TP inhibits viral DNA polymerase and thereby prevents viral genome replication, replication. The molecular structure of Acyclovir was determined by X-ray crystallography at 3.2 Å resolution. It has been shown that ACV-TP can be activated by chloride ions and it has been suggested that this activation may be the result of an interaction with a ligand.
ACV-TP binds to guanine residues in the DNA chain and prevents the formation of hydrogen bonds between guanine and adenine or cytosine residues in the same chain, preventing DNA replication.Formula:C10H13N5O4Purity:Min. 95%Color and Shape:White PowderMolecular weight:267.24 g/mol2-Mercaptobenzimidazole
CAS:2-Mercaptobenzimidazole is a chemical compound that can be used for the treatment of infectious diseases. It has been shown to have antioxidative properties and inhibit the growth of bacteria. 2-Mercaptobenzimidazole also has an effect on human serum, which may be due to its ability to bind with proteins in serum and form hydrogen bonds. 2-Mercaptobenzimidazole is stable at high temperatures and has been shown as an effective antimicrobial agent against gram positive and gram negative bacteria.
Formula:C7H6N2SPurity:Min. 99 Area-%Color and Shape:White/Off-White SolidMolecular weight:150.19 g/molBortezomib intermediate I
CAS:Bortezomib intermediate I is a metabolite of bortezomib, which is a research and development drug product. Bortezomib intermediate I is an impurity standard for bortezomib. Bortezomib intermediate I can be synthesized from the corresponding compound. It is an analytical standard used in pharmacopoeia and can be used as an API impurity or synthetic material in drug development. Bortezomib intermediate I has a high purity, natural origin, and a niche application. CAS No. 1248339-44-7Formula:C25H36BN5O4Purity:Min. 95%Color and Shape:White PowderMolecular weight:481.4 g/molN-Methyl zonisamide
CAS:N-Methyl zonisamide is a drug that is an impurity in Zonisamide. It is an analog of the drug and has been used as a research and development standard for Zonisamide. N-Methyl zonisamide can be synthesized from the corresponding nitrobenzene, aminobenzene, and formaldehyde. The synthesis can be performed by converting nitrobenzene to aminobenzene with sodium hydroxide in methanol, followed by conversion to N-methyl zonisamide with formaldehyde in ethanol. Pharmacopoeia standards for this compound are available from Sigma Aldrich, which can be purchased from our website.Formula:C9H10N2O3SPurity:Min. 95 Area-%Color and Shape:PowderMolecular weight:226.25 g/molLercanidipine impurity A
CAS:Lercandipine Impurity A is a metabolite of the drug lercandipine. It is synthesized in the body by oxidation at the benzylic position of the cinnamoyl moiety. This impurity may be present in lercandipine-containing drugs and products, as well as in other drugs and products containing lercandipine. Lercandipine Impurity A has been shown to inhibit the metabolism of lercandipine and may also have anti-inflammatory properties. It is used as an analytical standard for HPLC, pharmacopoeia, drug development, and metabolism studies. Lercandipine Impurity A is found in the following: -Impurities of Lercandipine -Custom synthesis -Lercandipine Drug Product -Synthetic -High purity -Pharmacopoeia -Drug development
Formula:C19H22N2O6Purity:Min. 95%Color and Shape:PowderMolecular weight:374.39 g/molOlmesartan EP Impurity C
CAS:Olmesartan medoxomil is a prodrug that is metabolized to the active form, olmesartan, in the liver. The esters of olmesartan medoxomil are metabolized by hydrolysis and by esterases. The most common side effects of olmesartan medoxomil are headache, dizziness, fatigue, nausea and diarrhea. Olmesartan medoxomil is used for the treatment of high blood pressure in adults. This drug also has anti-inflammatory properties due to its inhibition of prostaglandin synthesis.
Formula:C29H28N6O5Purity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:540.57 g/molDesethylene Ciprofloxacin hydrochloride
CAS:Desethylene ciprofloxacin hydrochloride is a metabolite of ciprofloxacin that is converted to the active form of the drug. Desethylene ciprofloxacin hydrochloride has a concentration-response relationship, which can be used for in vitro testing of pharmaceutical preparations. The chromatographic evaluation of this metabolite can be used to identify the presence of antibiotics in environmental samples. Desethylene ciprofloxacin hydrochloride is also a substrate for carbonyl reductase and piperazine, which are enzymes that produce an activated form of the metabolite.Formula:C15H16FN3O3·HClPurity:Min. 95%Color and Shape:Off-White Yellow PowderMolecular weight:341.77 g/molD-Ala-(19)-Semaglutide
D-Ala(19)-Semaglutide is a semaglutide impurity. The amino acid at position 19 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formula:C187H291N45O59Molecular weight:4,113.64 g/mol
